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B lymphocytes from the pulmonary lymphoid tissues were stimulated with a variety of thymus-independent
(TI) antigens by intratracheal (i.t.) immunization. Immune responses in the lungs and hilar lymph nodes
(HLN), which are part of the localized lymphoid tissue, as well as in the spleen, the systemic lymphoid organ,
were studied. Thus, primary i.t. immunization of mice with the TI-1 antigen trinitrophenyl-lipopolysaccharide
(TNP-LPS) elicited both antigen-specific and polyclonal plaque-forming cell responses from HLN, lung, and
splenic B lymphocytes. These responses appeared as early as 3 days after immunization and declined by day
7. Similar immunization with another TI-1 antigen, TNP-Brucella abortus, resulted in anti-TNP responses in
both pulmonary and systemic lymphoid tissues, although the kinetics of the antibody response were different
than those to TNP-LPS. Interestingly an i.t. immunization with a TI-2 antigen, TNP-Ficoll, failed to induce an
anti-TNP PFC response from HLN and lung B cells, although there was good antibody formation from splenic
B cells. Antibody response to TNP-Ficoll was restored in pulmonary tissues when mice were immunized with
TNP-Ficoll mixed with unconjugated B. abortus. In conclusion, our results indicate that TI-1 and TI-2 antigens
differ in their ability to induce antibody responses in the pulmonary lymphoid tissues. The inability of
TNP-Ficoll to elicit an antibody response in pulmonary lymphoid tissues has significance in the development of
vaccines containing bacterial polysaccharides.
The lung is a principal biological link between the body
and the outside environment, with a surface area about 30
times that of skin (41). The lungs and upper respiratory tract
constitute an important natural route for the entry of anti-
gens and potential pathogens into the body. The pulmonary
lymphoid system consists of a specialized lymphoepithelium
called bronchus-associated lymphoid tissue, lymphoreticular
aggregates and alveolar macrophages in the lungs and the
hilar lymph nodes (HLN) situated on either side of the
trachea near the bronchus (18).
Despite the importance of lung-associated immune tissues
in resistance to infection (1, 5, 8, 15, 34, 38), little informa-
tion is available on how different effector functions are
carried out by these cells and on the relationship between the
pulmonary and systemic immune responses. Studies by
other investigators to elucidate the mechanism of the appear-
ance of antibody responses in the pulmonary tissues of mice
and dogs have employed sheep erythrocytes (SRBC), which
belong to the category of thymus-dependent antigens (4, 10,
20, 22, 39). Since many of the microbial organisms contain
thymus-independent (TI) antigens (11, 27, 30, 43), we felt it
was important to analyze the capacity of the pulmonary
immune system to respond to these antigens. TI antigens are
classified as TI-1 and TI-2 based on their ability to induce
antibody formation in immune defective CBA/N mice and in
neonatal mice (6, 24, 28, 29). The TI-1 antigens employed in
this study were trinitrophenyl-lipopolysaccharide (TNP-
LPS) and TNP-Brucella abortus (TNP-BA). In the TI-2
antigen category, TNP-Ficoll was tested.
Recently, we have reported that TNP-Ficoll is unable to
induce antibody formation in the popliteal and inguinal
lymph nodes after subcutaneous immunization in the foot-
pads but elicited a good anti-TNP response from splenic B
cells of the same mice (12). Further, this dichotomy between
* Corresponding author.
the induction of lymph node and splenic B cell responses
was shown to be a general property of a variety of TI-2
antigens (S. N. Goud, A. M. Kaplan, and B. Subbarao, Reg.
Immunol., in press). Interestingly, the mesenteric lymph
node B cells, which belong to the category of gut-associated
lymphoid tissue, responded well to TNP-Ficoll. Therefore,
we wanted to determine if TNP-Ficoll could induce anti-
body-forming cells in lung and HLN B cells after intratra-
cheal (i.t.) immunization. In contrast to TNP-Ficoll, TNP-
BA has been shown to induce good plaque-forming cell
(PFC) responses in both popliteal and inguinal lymph nodes
as well as in the spleen after subcutaneous immunization
(12). Hence, in the present investigation, we tested the
ability of TNP-BA to induce antibody formation in pulmo-
nary lymphoid tissues. TNP-LPS was also tested because
LPS is present in most of the gram-negative bacteria which
cause respiratory distress syndrome in humans (35).
The results of this investigation show that a primary
antibody response in lung and HLN B lymphocytes was
obtained sooner with TNP-LPS than with TNP-BA. A
polyclonal antibody response was observed with TNP-LPS
in both lung and HLN B cells. Immunization with the TI-2
antigen TNP-Ficoll failed to elicit an antibody response in
the lungs and HLN, although a good response was obtained
in the spleens of these animals. Antibody response to
TNP-Ficoll was restored in pulmonary lymphoid tissues
when mice were immunized with TNP-Ficoll mixed with B.
abortus.
MATERIALS AND METHODS
Animals. Ten- to twelve-week-old DBA/2J female mice
obtained from Jackson Laboratory, Bar Harbor, Maine,
were used in this study. They were kept in microisolator
cages (Lab Products Inc., Maywood, N.J.). These cages
were housed in Bioclean Chambers (Hazleton Systems, Inc.
Aberdeen, Md.). The animals had free access to food (Purina
2035
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FIG. 1. Appearance of antibody-forming cells in pulmonary and systemic lymphoid tissues after a single primary i.t. immunization of mice
with TNP-LPS. The dose of antigen was 20 jig per mouse. Values represent the means + standard errors of PFC from three to six mice in
each group. The responses of the saline-control mice are shown in the bottom left-hand corner.
Lab Chow) and water. The mice were periodically tested for
common bacterial and viral pathogens and were found to be
negative.
Antigens. TNP-BA was made by conjugating heat-killed B.
abortus 1119-3 (National Veterinary Services Laboratory,
Ames, Iowa) with trinitrobenzene sulfonic acid by the
method of Mond et al. (24). TNP-Ficoll was prepared as
described earlier (16). TNP-LPS was prepared by the
method of Jacobs and Morrison (17), using LPS derived from
Escherichia coli O111.B4 (Difco Laboratories, Detroit,
Mich.).
Immunization. For i.t. immunization, each mouse was
anesthetized with 50 to 100 ,ul of a 30% solution of sodium
pentobarbital (Butler Co., Columbus, Ohio). A small inci-
sion was made in the neck region, the trachea was exposed,
and antigen was inoculated near the distal end of the trachea
with a Hamilton syringe and 30-gauge needle. The incision
was stapled with surgical autoclips (Becton Dickinson and
Co., Parsippany, N.J.).
Isolation of lymphocytes. At various times after immuniza-
tion, the animals were sacrificed and different lymphoid
organs were removed. Splenic lymphocytes were dispersed
by pressing the spleens against the bottom of a petri dish
with a disposable syringe plunger. The cell suspension was
transferred to a centrifuge tube and allowed to settle so the
debris could be collected at the bottom. The supernatant
containing the cells was aspirated, and the cells were washed
twice before use.
The HLN were collected in a petri dish with Hanks
balanced salt solution, the adhering fat was gently separated,
and the lymph nodes were minced finely with scissors. The
resulting suspension was filtered through a nylon screen to
remove debris and washed three times before use.
To collect lymphocytes from the lungs, the thoracic cavity
was opened and the lungs were perfused by injecting phys-
iological saline (containing 2 U of heparin per ml) into the
right ventricle of the heart until the color of the lungs turned
pale, indicating depletion of the majority of the RBC. Lung
lobes were removed free of trachea and lymph nodes and cut
into small pieces in Hanks balanced salt solution with
scissors. The tissue fragments were then homogenized in a
stomacher (Tekmar Co., Cincinnati, Ohio) for 2 min and
filtered through a nylon screen. The cell suspension was
washed three times and resuspended in Hanks balanced salt
solution. Slides were made by cytocentrifugation and stained
with Wright-Geimsa solution for differential counts.
Hemolytic PFC assay. Lymphocytes from different lym-
phoid organs were assayed for the number of direct immu-
noglobulin M (IgM) PFC by a glass slide modification of the
method of Jerne and Nordin (19). SRBC were coupled with
TNP by the procedure of Rittenberg and Pratt (36). For
estimating polyclonal antibody responses, SRBC were
coated with protein A (Pharmacia Fine Chemicals, Uppsala,
Sweden), using chromium chloride (13). For IgM responses
an appropriate dilution of rabbit anti-IgM was added to the
plaquing mixture. TNP-specific IgG or IgA PFC were esti-
mated by adding rabbit anti-mouse IgG or IgA antiserum
(Nordic Immunological Laboratories, Tilburg, The Nether-
lands) to the plaquing mixture after inhibiting IgM PFC with
goat anti-mouse IgM antiserum (Sigma Chemical Co., St.
Louis, Mo.).
Statistical analysis. Statistical significance of the data was
evaluated by the Student t test. The differences were con-
sidered significant if P values were less than 0.05.
RESULTS
Anti-TNP antibody responses in different lymphoid organs
after immunization with TNP-LPS. LPS is a potent mitogen
and a polyclonal activator of murine splenic B cells (7).
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TABLE 1. Polyclonal antibody responses in lungs and other
lymphoid organs after i.t. immunization with TNP-LPSa
Day after Polyclonal IgM PFC/106 lymphocytesb
immuni- Group
zation Spleen HLN Lung
3 TNP-LPS 5,667 ± 883* 1,117 ± 217* 2,302 ± 714*
Control 1,670 ± 95 70 + 10 24 ± 13
5 TNP-LPS 4,332 ± 469* 1,130 ± 231* 3,120 ± 451*
Control 2,250 ± 122 5 ± 1 10 ± 6
7 TNP-LPS 3,482 ± 175 274 + 110* 864 ± 579*
Control 3,107 ± 219 10 ± 2 8 ± 4
a Twenty micrograms of TNP-LPS in 40 ,ud of saline was injected i.t. For
control mice, a similar volume of 0.85% saline was injected.
b PFC were assayed by using protein A-coated SRBC and adding an
appropriate dilution of rabbit anti-mouse IgM antibody to the plaquing
mixture. The values are means + standard errors for two to four mice. *
Significantly different (P < 0.05) compared with control.
When mice were immunized i.t. with TNP-LPS, there was
good anti-TNP antibody responses not only from HLN and
lung B cells but also from splenic B cells (Fig. 1). The
antibody responses in all these lymphoid tissues were signif-
icantly higher (P < 0.05) than in control mice inoculated with
saline. The peak response in lungs occurred on day 5; the
results were significantly different (P < 0.05) from day 3 or
day 7 data.
Polyclonal antibody responses in pulmonary lymphoid tis-
sues induced by TNP-LPS. Infection with microorganisms
frequently results in the polyclonal activation of B lympho-
cytes. For example, Mycoplasma pneumoniae has been
found to induce polyclonal B cell activation in in vitro
cultures of mouse splenic B cells and human peripheral
blood cells (2, 3). Therefore, in the present study we wanted
to measure such polyclonal responses in pulmonary lym-
phoid tissues after an i.t. immunization of mice with TNP-
LPS. There are two ways by which we can measure poly-
clonal PFC. One procedure is by using SRBC coated with
unrelated haptens like 4-hydroxy-3-indo-5-nitrophenyl ace-
tate, fluorescein isothiocyanate, phosphoryl choline, etc.
The other method is by using protein A-coated SRBC and
adding rabbit anti-mouse IgM or IgG to the plaquing mixture
(13). We used the latter method because it is less time
consuming and more sensitive than the former.
The results shown in Table 1 indicate a significant (P <
0.05) increase in the polyclonal IgM antibody responses from
the HLN and lung B cells on 3, 5, and 7 days after i.t.
immunization. In the spleen, the polyclonal PFC remained
significantly higher (P < 0.05) up to 5 days postimmuniza-
tion. It should be pointed out that in the spleens of control
mice, there was a high level of cells that secreted IgM
spontaneously. This has been observed before, and such
cells were referred to as natural antibody-secreting cells (32).
TNP-BA-induced anti-TNP immune responses. In our pre-
vious study (12) it was found that TNP-BA elicited a good
antibody response from peripheral LN B cells. Therefore,
TNP-BA was selected for its ability to induce an anti-TNP
PFC response in pulmonary lymphoid tissues after i.t. im-
munization. The results indicate a significantly (P < 0.05)
higher antibody formation in both pulmonary and systemic
lymphoid tissues than in the controls. The peak antibody
response in the lungs occurred on day 9 (P < 0.05, compared
with other time points; Fig. 2).
Antibody responses to TNP-Ficoll in pulmonary lymphoid
tissues. In contrast to the TI-1 antigens, which elicited good
antibody responses in the pulmonary lymphoid tissues, the
TI-2 antigen TNP-Ficoll failed to induce anti-TNP responses
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FIG. 2. Antibody responses in pulmonary and systemic lymphoid tissues after a single primary i.t. immunization with TNP-BA. The dose
of antigen per mouse was 5 x 107 B. abortus organisms conjugated with TNP. Values represent the means + standard errors of PFC from
three to six mice in each group. The responses of the saline-control mice are shown in the bottom left-hand corner.
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TABLE 2. Anti-TNP antibody responses in pulmonary lymphoid
tissues after i.t. immunization of mice with TNP-Ficoll plus BA
Day after TNP-IgM PFC/106 lymphocytesa
immuni- Group
zation Spleen HLN Lung
5 TNP-Ficoll' 1,021 ± 300* 6 ± 4 1 ± 1
7 TNP-Ficoll 779 43* 4 ± 1 6 ± 2
9 TNP-Ficoll 639 ± 61* 3 ± 2 5 ± 2
12 TNP-Ficoll 307 ± 71* 1 ± 1 4 ± 3
7 TNP-Ficoll + 1,005 ± 150* 110 ± 21* 114 ± 23*
B. abortusc
9 TNP-Ficoll + 830 ± 49* 74 ± 9* 271 ± 34*
B. abortus
12 TNP-Ficoll + 570 ± 81* 51 ± 12* 95 ± 29*
B. abortus
Saline control 10 ± 6 2 ± 1 1 ± 1
a PFC were assayed by using TNP-coated SRBC. Values are means +
standard errors for six to eight mice in each group.
b Twenty micrograms of TNP-Ficoll was injected i.t. in a volume of 40 p. of
saline per mouse.
c Mice were injected i.t. with TNP-Ficoll (20 ,ug per animal) mixed with
about 5 x 107 unconjugated B. abortus cells in a total volume of 40 p.1 per
mouse. *, Significantly different (P < 0.05) compared with saline control.
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from the HLN and lung B cells of mice even up to 12 days
after an i.t. immunization. However, these animals exhibited
an excellent PFC response from their splenic B cells (Table
2). There were no IgG or IgA PFC responses in the pulmo-
nary lymphoid tissues of these mice (data not shown).
Immunization of mice with TNP-Ficoll plus B. abortus
induces antibody responses in pulmonary lymphoid tissues.
Since TNP-Ficoll alone was unable to induce antibody
responses in pulmonary lymphoid tissues, we immunized
mice with TNP-Ficoll mixed with unconjugated B. abortus,
by the i.t. route. This resulted in a statistically significant (P
< 0.05) increase in anti-TNP PFC from both HLN and lung
B cells over that for the saline controls. The peak response
in lungs was on day 9, and it was significantly different (P <
0.05) from the day 7 or day 12 response (Table 2).
Inflammation in lungs induced by different TI antigens. To
test whether the ability of an antigen to induce inflammation
in the respiratory tract is related to the appearance of
antibody responses in the lung, we examined lung homo-
genates for the presence of neutrophils, eosinophils, (poly-
morphs), monocytes, etc. The results show an enhancement
(P < 0.05) in the number of polymorphs, monocytes, and
lymphocytes in TNP-LPS- and TNP-BA-immunized mice
b *
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FIG. 3. Total number of different types of lymphoid and myeloid cells present in the lung homogenates of mice i.t. immunized with
different antigens. (a) Animals were immunized with 20 ,ug of TNP-LPS per mouse. (b) Animals were immunized with TNP-BA. The dose
of antigen per mouse was 5 x 107 B. abortus organisms conjugated with TNP. (c) Animals received 20 p.g of TNP-Ficoll per mouse. (d)
Animals received 20 jig of TNP-Ficoll mixed with 5 x 107 unconjugated B. abortus organisms per mouse. On the day of the assay, animals
were sacrificed, the lungs were processed as described in Materials and Methods, and the lung cell suspension was stained with
Wright-Giemsa stain for differential counts. The values represent the means + standard errors of the different cell populations per mouse. The
cell counts from the lungs of saline-control animals are shown in the lower left-hand corner of panel a. Three to six mice were used for each
time point in the TNP-LPS- and TNP-BA-immunized groups, and 6 to 10 mice were used for each time point in the TNP-Ficoll and
TNP-Ficoll-plus-BA groups.
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compared with saline controls (Fig. 3a and b). The biggest
increase in lymphocytes coincided with the peak of the PFC
response. But the TI-2 antigen TNP-Ficoll, which failed to
induce anti-TNP PFC in the lymphoid tissues of the respira-
tory tract, did not cause an increase (P > 0.05) in the number
of granulocytes or monocytes (Fig. 3c). However i.t. immu-
nization of mice with TNP-Ficoll plus B. abortus resulted in
a significant (P < 0.05) increase in the number of inflamma-
tory cells and anti-TNP PFC in the lung (Fig. 3d).
DISCUSSION
The most significant finding of this investigation was the
appearance of antibody-forming cells within the lung and
HLN B cells after a primary i.t. immunization of mice with
the TI-1 antigens TNP-LPS and TNP-BA but not with the
TI-2 antigen TNP-Ficoll. Both polyclonal and anti-TNP PFC
were found as early as 3 days after the administration of
TNP-LPS. This appears to be a unique property of TI-1
antigens, since in previous studies which employed thymus-
dependent antigens, the primary responses in the lungs and
HLN were small and appeared late (21-23).
What is the basis for the appearance of effector B cells in
lungs after a single immunization with TI antigens? This is a
difficult question to resolve at this time, and we cannot as yet
exclude one possibility over another. One reason for such a
rapid appearance of antibody responses in the TNP-LPS-
immunized mice might have been the stimulation of resident
B cells in the HLN and lung parenchyma by the LPS.
Alternatively, LPS could have caused the migration of
antigen-specific B cells or plasma cells into the lung as a
result of inflammation. Our cytological examination of lung
homogenates showed the presence of inflammation in the
lung parenchyma of animals immunized with TNP-LPS (Fig.
3). Other investigators have also demonstrated the occur-
rence of inflammation in the respiratory tract of animals
inoculated with LPS (9, 14).
i.t. immunization with TNP-BA resulted in similar anti-
body responses in both pulmonary and systemic lymphoid
tissues, although the peaks of the antibody responses in the
lungs were different than those in TNP-LPS-immunized
mice. This might have been due to the structural and
functional differences between the E. coli-derived LPS and
the B. abortus-derived LPS (25, 26).
An interesting result of this study was the failure of
TNP-Ficoll to induce a PFC response from the HLN and
lung B cells despite a good response from the splenic B cells
of the mice. Since TNP-Ficoll is a soluble antigen, its
unresponsiveness in pulmonary lymphoid tissues may be
due to the poor retention of the antigen in the pulmonary
tissues or to the failure of TNP-Ficoll to induce inflammation
in the lungs. Our present results confirm the absence of
inflammation in the lungs of TNP-Ficoll-immunized mice.
The antibody response to TNP-Ficoll in pulmonary tissues
was restored when the mice were immunized with TNP-
Ficoll mixed with B. abortus. This shows the importance of
the inflammatory agents or adjuvants in the antibody re-
sponses to soluble antigens. This observation is in agreement
with our earlier study, in which popliteal and inguinal LN B
cells responded to TNP-Ficoll when mice were injected in
the footpads with TNP-Ficoll plus B. abortus (12). A previ-
ous study by others has shown that the concentration of
soluble protein antigens retained in the HLN was 10 times
more in animals treated with inflammatory agents such as
Mycobacterium bovis BCG or carrageenan than in normal
controls (33). Also, inhalation of antigens into inflammed but
not normal lungs resulted in the development of high levels
of circulating antibodies and activated T cells in the lungs of
rabbits (42).
The absence of inflammation in the lungs may not be the
only reason for the lack of TI-2 antigen-specific PFC re-
sponses in pulmonary lymphoid tissues, because another
soluble TI-2 antigen, polyvinylpyrrolidone (PVP), failed to
elicit anti-PVP PFC responses from the lung and HLN B
cells even after mice were immunized i.t. with PVP mixed
with unconjugated B. abortus (data not shown). Also, there
was no antibody response from popliteal and inguinal LN B
cells of mice immunized subcutaneously in the footpads with
PVP plus B. abortus (Goud et al., in press). This observation
is in contrast to the data for TNP-Ficoll plus B. abortus.
Currently we are attempting to analyze the role of various
cells in the antibody responses of TI-2 antigens in pulmonary
lymphoid tissues by performing in vitro cell mixing experi-
ments with accessory, B and T cells derived from the spleen,
HLN, and lung.
Studies of the pulmonary immune responses to TI antigens
has relevance to the development of vaccines for human
respiratory pathogens like pneumococci, Hemophilus influ-
enzae, etc. TNP-Ficoll is a prototype TI-2 antigen, a cate-
gory to which a variety of bacterial polysaccharides belong.
Our present study shows that TNP-Ficoll induces an anti-
body response in the pulmonary lymphoid tissues only when
it is administered with B. abortus. But such use of particu-
late adjuvants may not be feasible in human clinical trials.
One alternative possibility is combined immunization by the
oral and intranasal routes. This procedure was found to be
effective in conferring protective immunity to both the upper
and lower respiratory tract of mice against Sendai virus and
pertussis toxin (31, 37). The rationale behind this method is
that the oral immunization primes the B lymphocytes from
the gut-associated lymphoid tissues such as mesenteric
lymph nodes and Peyer's patches and these activated cells
migrate to the respiratory tract upon secondary challenge
(40). In this regard we have found that, in contrast to
peripheral LN (axillary, brachial, popliteal, and inguinal)
cells, the B lymphocytes from mesenteric lymph nodes make
good anti-TNP PFC responses to TNP-Ficoll in in vitro
culture experiments (Goud et al., in press). Therefore, it will
be interesting to study the antibody responses in the lung
after oral and i.t. immunization with TNP-Ficoll; such stud-
ies are in progress.
In conclusion, the results of the present study indicate that
after a primary i.t. immunization with the TI-1 antigens
TNP-LPS and TNP-BA, there were antigen-specific and
polyclonal antibody responses in pulmonary lymphoid tis-
sues. In contrast, the TI-2 antigen TNP-Ficoll failed to elicit
such a response. The antibody response to TNP-Ficoll was
restored in the lung and HLN B cells when mice were
immunized with TNP-Ficoll mixed with B. abortus.
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